Advanced search
1 file | 1.18 MB

Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients

(2012) EUROPEAN JOURNAL OF CANCER. 48(13). p.2004-2011
Author
Organization
Keywords
PLASMACYTOID DENDRITIC CELLS, SINGLE NUCLEOTIDE POLYMORPHISM, REGULATORY T-CELLS, TRYPTOPHAN CATABOLISM, MALIGNANT-MELANOMA, EXPRESSION, IDO, INHIBITORS, CONVERSION, TREGS, Sentinel node, Regulatory T cell, Prognosis, Melanoma, 3-dioxygenase, Indoleamine 2

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.18 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Speeckaert, Reinhart, Karim Vermaelen, Nanja van Geel, Philippe Autier, Jo Lambert, Marc Haspeslagh, Mireille Van Gele, et al. 2012. “Indoleamine 2,3-dioxygenase, a New Prognostic Marker in Sentinel Lymph Nodes of Melanoma Patients.” European Journal of Cancer 48 (13): 2004–2011.
APA
Speeckaert, R., Vermaelen, K., van Geel, N., Autier, P., Lambert, J., Haspeslagh, M., Van Gele, M., et al. (2012). Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients. EUROPEAN JOURNAL OF CANCER, 48(13), 2004–2011.
Vancouver
1.
Speeckaert R, Vermaelen K, van Geel N, Autier P, Lambert J, Haspeslagh M, et al. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients. EUROPEAN JOURNAL OF CANCER. 2012;48(13):2004–11.
MLA
Speeckaert, Reinhart, Karim Vermaelen, Nanja van Geel, et al. “Indoleamine 2,3-dioxygenase, a New Prognostic Marker in Sentinel Lymph Nodes of Melanoma Patients.” EUROPEAN JOURNAL OF CANCER 48.13 (2012): 2004–2011. Print.
@article{1955528,
  author       = {Speeckaert, Reinhart and Vermaelen, Karim and van Geel, Nanja and Autier, Philippe and Lambert, Jo and Haspeslagh, Marc and Van Gele, Mireille and Thielemans, Kris and Neyns, Bart and Roche, Nathalie and VERBEKE, NATACHA and Deron, Philippe and Speeckaert, Marijn and Brochez, Lieve},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  keyword      = {PLASMACYTOID DENDRITIC CELLS,SINGLE NUCLEOTIDE POLYMORPHISM,REGULATORY T-CELLS,TRYPTOPHAN CATABOLISM,MALIGNANT-MELANOMA,EXPRESSION,IDO,INHIBITORS,CONVERSION,TREGS,Sentinel node,Regulatory T cell,Prognosis,Melanoma,3-dioxygenase,Indoleamine 2},
  language     = {eng},
  number       = {13},
  pages        = {2004--2011},
  title        = {Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients},
  url          = {http://dx.doi.org/10.1016/j.ejca.2011.09.007},
  volume       = {48},
  year         = {2012},
}

Altmetric
View in Altmetric
Web of Science
Times cited: